We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Mulling Cash Offer for Swiss Vaccine Maker Berna
Novartis Mulling Cash Offer for Swiss Vaccine Maker Berna
December 19, 2005
Looking to further expand its presence in the vaccines market, Novartis is considering making a cash counteroffer for Swiss manufacturer Berna Biotech, which earlier this month agreed to be purchased in an all-stock deal by Dutch drug firm Crucell.